Molecular Devices supplies high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. Its systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics and combinatorial chemistry by facilitating the high-throughput and cost-effective identification and evaluation of drug candidates. Molecular Devices' product solutions are based on its advanced core technologies that integrate its expertise in engineering, molecular and cell biology, electrophysiology, and chemistry. Molecular Devices enables its customers to improve their research productivity and effectiveness, which ultimately accelerates the complex process of discovering and developing new drugs. Molecular Devices has a record of developing innovative, first-to-market products that include instrumentation, software and reagent systems. Molecular Devices is based in Sunnyvale, California, and has offices in Union City, California, Downingtown, Pennsylvania, England, Germany, Korea, China and Japan.